India Pharma Chiefs On Supply Chain Learnings From Auto Sector, New ‘PAGE’ On Skilling

Leaders from India’s top drug makers discuss efforts to operationalize a world-class skilling institute, backed by tie-ups with organizations like the PDA, ISPE and also taking a leaf out of the automobile industry’s book to build supply chain resilience. They also exuded confidence on moving up the innovation value chain.

L- R: Sathya Prathipati,, senior partner & lead, lifesciences practice (Asia), McKinsey & Co; Umang Vohra, global CEO& MD, Cipla; GV Prasad, co-chairman & MD, Dr Reddy's Labs; Nilesh Gupta, MD, Lupin; Dilip Shanghvi, MD, Sun Pharma; & Pankaj Patel, chairman, Zydus Lifesciences

US Food and Drug Administration (FDA) Commissioner Robert Califf appears to have contributed to nudging a pivotal effort to build biopharma’s talent pool in India and fostering a culture of manufacturing and quality excellence.

Pharma leaders at a recent summit indicated that discussions with the FDA Commissioner on his visit to the country helped...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia